StockTipsArenaBeta

SELL Fortis Healthcare — Manas Jaiswal

SELLFortis Healthcare
Fortis Healthcare share price target & all analyst calls

byManas JaiswalHorizon: NA (inferred Swing (≤2wk))25 Sept 2026via CNBC Awaaz.

Entry₹856.45Inferred
Target₹825
Total upside +3.67% (call closed)
Stop loss₹871-1.70% risk
Exit₹82528 Sept 2026, 9:35 am
Target hit+3.67%0.00%upside left
Follow Manas Jaiswal for new calls(32% target hit, 426 closed calls)Get alertsWatch FORTIS for new buy/sell callsGet alertsSee 1 active Swing call on FORTISSee 282 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 28 Sept 2026
6 supporting5 neutral4 opposing
Supports the SELL call (6)

Fortis Healthcare shares in focus as Supreme Court allows forensic audit to proceed

NewsEt-Markets·28 Sept · today

(opens in new tab)

Fortis Healthcare shares in focus after SC allows forensic audit to go ahead

NewsCnbc-Tv18·28 Sept · today

(opens in new tab)

1 other SEBI-registered advisor has an active swing SELL call on this stock, issued in the last 14 days

Advisor consensus · same horizon·27 Sept · today

Fortis audit order could drag listed firms into promoters' personal debt cases: InGovern

NewsEt-Markets·22 Sept · 5d ago

(opens in new tab)

Fortis Healthcare moves Supreme Court to stop forensic audit of IHH takeover

NewsCnbc-Tv18·16 Sept · 2w ago

(opens in new tab)
Neutral / worth noting (5)

Independent Forensic Audit Will Attest To Fortis' Non-involvement In Singh Brothers' Share Transfers: Company

NewsNdtv-Profit·27 Sept · today

(opens in new tab)

Fortis says it is ‘complete stranger’ to Daiichi-Singh Brothers dispute after SC allows forensic audit | Shares in focus

NewsLivemint·27 Sept · today

(opens in new tab)

Fortis Healthcare Ltd is disclosing information regarding a material litigation filed by Northern TK Venture Pte Ltd against Daiichi Sankyo Company, Limited before the Tokyo District Court in Japan. T

BSE · Company Update·25 Sept · 2d ago

(opens in new tab)

How Delhi HC's Fortis Healthcare order safeguards investors, making listed firms answerable for promoters' personal debt

NewsLivemint·23 Sept · 4d ago

(opens in new tab)

Fortis Healthcare Ltd is disclosing an update on a material litigation filed by its promoter shareholder, Northern TK Venture Pte Ltd (NTK), against Daiichi Sankyo Company, Limited in Japan. The discl

BSE · Company Update·11 Sept · 2w ago

(opens in new tab)
Weighs against the SELL call (4)

Fortis Healthcare signs 29-year pact for 400+ bed super speciality hospital in Delhi

NewsCnbc-Tv18·16 Sept · 2w ago

(opens in new tab)

Fortis Healthcare has signed definitive agreements to provide healthcare services to a new 400+ bedded super specialty hospital in Ashok Vihar, New Delhi.

NSE · Press Release·16 Sept · 2w ago

(opens in new tab)

Fortis Hospotel Limited, a subsidiary of Fortis Healthcare, has signed definitive agreements to provide healthcare services to a new 400+ bedded super specialty hospital in Ashok Vihar, New Delhi. The

BSE · Company Update·16 Sept · 2w ago

(opens in new tab)

Fortis Hospotel Limited, a subsidiary of Fortis Healthcare, has signed definitive agreements with Seth Sunder Lal Jain Charitable Eye Hospital to provide healthcare services to a new 400+ bedded super

BSE · Company Update·16 Sept · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Fortis Healthcare

All analyst calls on Fortis Healthcare

More from Manas Jaiswal

Every call and its outcome